Meticulous Research®, a renowned global market research company, has released a comprehensive report titled “Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (mAb, Vaccine), Research], End User - Global Forecast to 2030.” This report underscores the burgeoning growth of the single-use bioreactors market, projected to reach $10.3 billion by 2030, with a compound annual growth rate (CAGR) of 15.8%.
Download Sample Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5005
Market Drivers
The growth of the single-use bioreactors market is primarily driven by the following factors:
- Adoption of Disposable Technologies: The increasing adoption of disposable technologies in the pharmaceutical and biotechnology sectors is a key catalyst for market growth. Single-use bioreactors offer advantages such as reduced cleaning requirements, lower capital investments, smaller footprints, and minimized risks of cross-contamination.
- Capacity Expansions of Biopharmaceutical Plants: As the demand for biopharmaceuticals continues to rise, companies are expanding their production capabilities. This expansion often involves the incorporation of single-use bioreactor systems to enhance efficiency and scalability.
- Increasing Pharmaceutical RD Expenditures: The rise in research and development expenditures in the pharmaceutical sector drives the demand for advanced bioprocessing technologies, including single-use bioreactors. The focus on developing novel therapeutics and biosimilars further fuels this trend.
- Adoption of Biosimilars: The growing acceptance and demand for biosimilars have resulted in increased biopharmaceutical production, necessitating the use of flexible and efficient manufacturing processes facilitated by single-use technologies.
- Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases globally underscores the need for effective biopharmaceutical solutions, further driving the demand for single-use bioreactors.
Future Outlook of the Single-Use Bioreactors Market
The global single-use bioreactors market is segmented based on product, type, cell type, application, end user, and geography.
Browse In Depth: https://www.meticulousresearch.com/product/single-use-bioreactors-market-5005
Product Segmentation
- Single-Use Bioreactor Systems: This segment is anticipated to hold the largest share in 2023 due to its numerous advantages, including flexibility, ease of use, and reduced risk of contamination. The systems are classified into capacities such as up to 10L, 11L-500L, 501L-1000L, and above 1001L.
- Media Bags: Media bags are categorized into 2D, 3D, and linear formats. They are essential for the cultivation of cells in biopharmaceutical production.
- Filtration Assemblies: This product category also plays a crucial role in the bioprocessing workflow, ensuring the purity and integrity of the final products.
- Others: Other products complement the primary offerings in the market, catering to specialized needs.
Type Segmentation
The market is divided into several types, with stirred-tank bioreactors expected to dominate in 2023. This preference is largely due to their widespread use in Chinese Hamster Ovary (CHO) cell lines and suspension culture, as well as their effectiveness in large-volume bioproduction. Stirred-tank bioreactors offer significant advantages over traditional designs, minimizing operational challenges and enhancing productivity.
Cell Type Segmentation
In terms of cell type, mammalian cells are projected to account for the largest share in 2023. This trend is attributed to the growing focus on producing complex biomolecules such as monoclonal antibodies (mAbs) and therapeutic proteins, which predominantly utilize mammalian cells in both commercial and research bioproduction settings.
Application Segmentation
The commercial bioproduction segment is expected to lead the market in 2023. Factors contributing to its dominance include the rising incidence of chronic diseases, the increasing demand for biopharmaceuticals, and regulatory reforms favoring biosimilars. The commercial applications span various areas, including mAb production, vaccine development, and therapeutic protein production.
End User Segmentation
The Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) segment is projected to experience the highest CAGR during the forecast period. This growth is driven by pharmaceutical companies' increasing reliance on outsourcing, allowing CDMOs to leverage their expertise and resources to streamline biomanufacturing processes.
Geographic Analysis
The report provides an in-depth geographic analysis, covering major regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East Africa.
- North America: The North American market is characterized by a strong presence of leading biopharmaceutical companies, high RD expenditures, and advanced healthcare infrastructure.
- Europe: In 2023, Europe is expected to hold the largest share of the single-use bioreactors market. This can be attributed to the region's supportive government policies and regulatory frameworks that promote biopharmaceutical usage for various health conditions. Additionally, companies in Europe are expanding their manufacturing capacities to meet the growing demand for biopharmaceuticals.
- Asia-Pacific: The Asia-Pacific region is anticipated to witness significant growth due to increasing investments in biopharmaceutical production and rising healthcare expenditures. Countries such as China and India are emerging as key players in the biopharmaceutical industry, with a focus on expanding their biomanufacturing capabilities.
- Latin America and the Middle East Africa: These regions are expected to see gradual growth in the single-use bioreactors market as healthcare systems evolve and the demand for biopharmaceuticals increases.
Key Players in the Market
Several key players are prominent in the single-use bioreactors market, including:
- Merck KGaA (Germany): A global leader in life sciences and biopharmaceutical manufacturing solutions, Merck offers a range of innovative single-use technologies.
- Danaher Corporation (U.S.): Known for its advanced scientific instrumentation and bioprocessing solutions, Danaher has a strong presence in the single-use market.
- Sartorius AG (Germany): A leading provider of bioprocess solutions, Sartorius offers a comprehensive portfolio of single-use bioreactors.
- Thermo Fisher Scientific Inc. (U.S.): This company is recognized for its extensive range of bioprocessing equipment and single-use technologies.
- Eppendorf AG (Germany): A key player in the life sciences sector, Eppendorf specializes in lab equipment, including single-use bioreactors.
- Solaris Biotechnology srl (Italy): Solaris focuses on providing innovative bioprocessing solutions, including single-use bioreactors.
- Cellexus International Ltd. (U.K.): Cellexus specializes in single-use bioreactor systems designed for efficient cell culture processes.
- CESCO Bioengineering Co., Ltd. (Taiwan): CESCO is known for its contributions to bioprocessing and biotechnology through single-use technologies.
- PBS Biotech, Inc. (U.S.): PBS offers cutting-edge single-use bioreactor solutions that cater to the needs of biopharmaceutical manufacturers.
- Distek, Inc. (U.S.): Distek provides innovative bioprocessing solutions, including single-use technologies.
- Infors AG (Switzerland): Infors is recognized for its expertise in bioprocess technology and offers a range of single-use bioreactors.
Quick Buy – Single-use Bioreactors Market – Global Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/10872692
Conclusion
In conclusion, the single-use bioreactors market is poised for remarkable growth, driven by technological advancements, increasing RD expenditures, and the rising demand for biopharmaceuticals. As companies continue to embrace single-use technologies for their advantages in efficiency and flexibility, the market is set to evolve significantly in the coming years. With the support of key players and regional growth dynamics, the single-use bioreactors market will likely thrive and meet the growing demands of the pharmaceutical and biotechnology industries.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
